New Zealand markets closed

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1650-0.0025 (-1.49%)
At close: 04:00PM EDT
0.1680 +0.00 (+1.82%)
Pre-market: 05:20AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
4,787
6,830
21,030
12,432
Other short-term investments
8,969
21,933
28,592
46,247
Total cash
13,756
28,763
49,622
58,679
Other current assets
1,737
5,719
1,321
-
Total current assets
15,543
34,532
50,993
61,555
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,703
7,103
6,817
5,656
Accumulated depreciation
-1,695
-1,369
-1,037
-797
Net property, plant and equipment
5,008
5,734
5,780
4,859
Goodwill
1,336
1,336
1,336
1,336
Intangible assets
3,017
3,017
3,017
3,017
Other long-term assets
200
200
200
199.95
Total non-current assets
9,561
10,287
10,333
9,412
Total assets
25,104
44,819
61,326
70,967
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
514
618
937
349.941
Accrued liabilities
1,176
1,705
1,343
1,094
Deferred revenues
0
721
33
643
Other current liabilities
271
585
576
1,058
Total current liabilities
2,622
4,286
4,348
3,568
Non-current liabilities
Deferred tax liabilities
341
341
341
341.265
Total non-current liabilities
3,236
3,896
4,484
3,669
Total liabilities
5,858
8,182
8,832
7,237
Stockholders' equity
Common stock
22
22
22
3,818
Retained earnings
-175,573
-152,631
-131,634
-107,507
Accumulated other comprehensive income
-221
-824
-145
228.172
Total stockholders' equity
19,246
36,637
52,494
63,731
Total liabilities and stockholders' equity
25,104
44,819
61,326
70,967